STRO
Sutro Biopharma·NASDAQ
--
--(--)
--
--(--)
3.20 / 10
Netural
The fundamental analysis reveals a stock with average profitability and liquidity but below-peer asset valuation (Asset-MV factor scores 0). Key positives include a healthy 92.3% revenue growth YoY and a 15.5% interest-coverage ratio, while challenges remain in asset and cash valuation. Overall, the fundamental score of 3.2/10 classifies the profile as subpar, warranting prudence.
Analysis Checks(9/10)
Revenue-MV
Value-0.43
Score2/3
Weight15.85%
1M Return7.73%
Value-0.43
Score2/3
Weight15.85%
1M Return7.73%
Days sales outstanding
Value18.63
Score2/3
Weight1.76%
1M Return1.10%
Value18.63
Score2/3
Weight1.76%
1M Return1.10%
Net income-Revenue
Value-0.17
Score2/3
Weight16.16%
1M Return8.45%
Value-0.17
Score2/3
Weight16.16%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.62%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.62%
1M Return-1.11%
Asset-MV
Value-0.50
Score0/3
Weight11.53%
1M Return5.75%
Value-0.50
Score0/3
Weight11.53%
1M Return5.75%
Total operating revenue (YoY growth rate %)
Value92.31
Score2/3
Weight1.73%
1M Return1.11%
Value92.31
Score2/3
Weight1.73%
1M Return1.11%
Profit-MV
Value0.46
Score2/3
Weight16.15%
1M Return8.45%
Value0.46
Score2/3
Weight16.15%
1M Return8.45%
PB-ROE
Value-0.69
Score3/3
Weight21.89%
1M Return12.83%
Value-0.69
Score3/3
Weight21.89%
1M Return12.83%
Operating revenue (YoY growth rate %)
Value92.31
Score2/3
Weight0.67%
1M Return0.43%
Value92.31
Score2/3
Weight0.67%
1M Return0.43%
Cash-MV
Value-0.07
Score2/3
Weight15.87%
1M Return8.41%
Value-0.07
Score2/3
Weight15.87%
1M Return8.41%
Revenue-MV
Value-0.43
Score2/3
Weight15.85%
1M Return7.73%
Value-0.43
Score2/3
Weight15.85%
1M Return7.73%
Total operating revenue (YoY growth rate %)
Value92.31
Score2/3
Weight1.73%
1M Return1.11%
Value92.31
Score2/3
Weight1.73%
1M Return1.11%
Days sales outstanding
Value18.63
Score2/3
Weight1.76%
1M Return1.10%
Value18.63
Score2/3
Weight1.76%
1M Return1.10%
Profit-MV
Value0.46
Score2/3
Weight16.15%
1M Return8.45%
Value0.46
Score2/3
Weight16.15%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight16.16%
1M Return8.45%
Value-0.17
Score2/3
Weight16.16%
1M Return8.45%
PB-ROE
Value-0.69
Score3/3
Weight21.89%
1M Return12.83%
Value-0.69
Score3/3
Weight21.89%
1M Return12.83%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.62%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.62%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value92.31
Score2/3
Weight0.67%
1M Return0.43%
Value92.31
Score2/3
Weight0.67%
1M Return0.43%
Asset-MV
Value-0.50
Score0/3
Weight11.53%
1M Return5.75%
Value-0.50
Score0/3
Weight11.53%
1M Return5.75%
Cash-MV
Value-0.07
Score2/3
Weight15.87%
1M Return8.41%
Value-0.07
Score2/3
Weight15.87%
1M Return8.41%
Is STRO undervalued or overvalued?
- STRO scores 3.20/10 on fundamentals and holds a Fair valuation at present. Backed by its 0.00% ROE, -205.18% net margin, -6.10 P/E ratio, -15.14 P/B ratio, and -1060.65% earnings growth, these metrics solidify its Netural investment rating.
